| __timestamp | CRISPR Therapeutics AG | Verona Pharma plc |
|---|---|---|
| Wednesday, January 1, 2014 | 1513000 | 4101058 |
| Thursday, January 1, 2015 | 12573000 | 10763215 |
| Friday, January 1, 2016 | 42238000 | 5579049 |
| Sunday, January 1, 2017 | 69800000 | 32051299 |
| Monday, January 1, 2018 | 113773000 | 24482286 |
| Tuesday, January 1, 2019 | 179362000 | 43892589 |
| Wednesday, January 1, 2020 | 266946000 | 44505000 |
| Friday, January 1, 2021 | 438633000 | 79406000 |
| Saturday, January 1, 2022 | 461645000 | 49283000 |
| Sunday, January 1, 2023 | 387332000 | 17282730 |
| Monday, January 1, 2024 | 320653000 |
Unleashing the power of data
In the rapidly evolving biotech sector, research and development (R&D) spending is a key indicator of a company's commitment to innovation. Over the past decade, CRISPR Therapeutics AG and Verona Pharma plc have demonstrated contrasting strategies in their R&D investments.
CRISPR Therapeutics AG has consistently increased its R&D budget, peaking in 2022 with a staggering 3,950% increase from 2014. This surge underscores their aggressive pursuit of cutting-edge gene-editing technologies.
In contrast, Verona Pharma plc has shown a more measured approach, with a 1,200% increase in R&D spending over the same period. Their focus remains on respiratory diseases, reflecting a strategic yet cautious expansion.
As we look to the future, these trends highlight the diverse paths companies take in the quest for medical breakthroughs.
Research and Development Investment: Zoetis Inc. vs Verona Pharma plc
Research and Development Investment: Sarepta Therapeutics, Inc. vs Verona Pharma plc
Ascendis Pharma A/S vs Verona Pharma plc: Strategic Focus on R&D Spending
Ascendis Pharma A/S vs CRISPR Therapeutics AG: Strategic Focus on R&D Spending
Ionis Pharmaceuticals, Inc. or Verona Pharma plc: Who Invests More in Innovation?
Who Prioritizes Innovation? R&D Spending Compared for Opthea Limited and CRISPR Therapeutics AG
Research and Development: Comparing Key Metrics for Verona Pharma plc and Catalyst Pharmaceuticals, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Verona Pharma plc and HUTCHMED (China) Limited
R&D Spending Showdown: Verona Pharma plc vs Dynavax Technologies Corporation
Research and Development: Comparing Key Metrics for Verona Pharma plc and Celldex Therapeutics, Inc.
Comparing Innovation Spending: CRISPR Therapeutics AG and Veracyte, Inc.
Research and Development: Comparing Key Metrics for CRISPR Therapeutics AG and Bausch Health Companies Inc.